Effects on loft ventricular mass and function of low doses of enalapril for systemic hypertension

American Journal of Cardiology

Volumn 81, Issue 1, 1998, Pages 87-90

  González Juanatey, José Ramón ^a   Reino, Antonio Pose ^a   García Acuña, José María ^a   Román, Alfonso Varela ^a   Gómez, Carlos Calvo ^a   Cabezas Cerrato, José ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; AGED; BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ECHOGRAPHY; HEART RATE; MIDDLE AGED;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ENALAPRIL; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 0031594391     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00860-6     Document Type: Article

References (13)

1. 1. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodeling and growth. Hypertension 1993;21:391-397.
2. 2. Schiffrin EL. Effect of antihypertensive therapy on small artery structure in hypertensive patients. Hypertension 1995;26:716-717.
3. 3. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive therapy on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:478-481.
4. 4. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs in rats with experimental heart failure. Circulation 1995;92:3105-3112.
5. 5. Asmar RJ, Journo HJ, Lacolley PJ, Santoni JP, Billaud E, Levy BI, Safar ME. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens 1988;6 (suppl 3):S33-S39.
6. 6. Bielen EC, Fagard RH, Lijnen PJ, Tjandra-maga TB, Verbesselt R, Amery AK. Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension. Am J Cardiol 1992;69:1200-1206.
7. 7. González-Juanatey JR, Pose A, García JM, Castelo V, Amaro A, Calvo C, Gil M. Left ventricular systolic function after marked reduction of left ventricular hypertrophy induced by 5 years' enalapril treatment. Eur Heart J 1995;16:1981-1986.
8. 8. Cleland JGF, Morgan K. Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research. Curr Opin Cardiol 1996;11:252-262.
9. 9. González-Juanatey JR, Pose A, Varela A, García-Acuña JM, Fernández JA, Cabezas J. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. Am J Cardiol 1997;79: 373-376.
10. 10. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation 1977;55:613-618.
11. 11. Schmieder RE, Rockstroh JK, Messerli FH. Antihypertensive therapy. To stop or not to stop? JAMA 1991;265:1566-1573.
12. 12. Finnerty FA Jr. Stepped-down therapy versus intermittent therapy in systolic hypertension. Am J Cardiol 1990;66:1373-1380.
13. 13. Pacher R, Stanek B, Globits S, Berger R, Hulsmann M, Wutte M, Frey B, Schuller M, Hartter E, Ogris E. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Eur Heart J 1996;17:1223-1232.